Skip to main content

Advertisement

SpringerLink
Log in

Acute Myocardial Infarction in Chinese Medicine Hospitals in China from 2006 to 2013: An Analysis of 2311 Patients from Hospital Data

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To assess the trends in characteristics, treatments, and outcomes of acute myocardial infarction (AMI) patients in tertiary Chinese medicine (CM) hospitals in China between 2006 and 2013.

Methods

This retrospective study was based on two nationwide epidemiological surveys of AMI in tertiary CM hospitals during 2 years (2006 and 2013). Patients admitted to the hospital for AMI were enrolled. Hospital records were used as the data source. Case data were derived regarding baseline characteristics, treatments, and outcomes of patients to assess changes from 2006 to 2013. Logistic regression was used to analyze the relationship between prognosis, general influencing factors of disease, and various treatment measures.

Results

Totally 26 tertiary CM hospitals in 2006 and 29 tertiary CM hospitals in 2013 (18 were repetitive) were surveyed. A total of 2,311 patients with AMI were enrolled (1,094 cases in 2006 and 1,217 cases in 2013). From 2006 to 2013, the mean age did not significantly change, but the proportion of patients younger than 65 years increased. The prevalence of risk factors such as hypertension, diabetes, and hyperlipidemia also increased. Significant increases were observed in primary percutaneous coronary intervention [20.48% (2006) vs. 24.90% (2013)] and revascularization [36.11% (2006) vs. 52.42% (2013)]. In-hospital mortality decreased from 11.15% in 2006 to 10.60% in 2013. A mortality logistic regression analysis identified reperfusion therapy [odds ratio (OR), 0.222; 95% confidence interval (CI), 0.106–0.464], Chinese patent medicines (OR, 0.394; 95% CI, 0.213–0.727), and CM decoctions (OR, 0.196; 95% CI, 0.109–0.353) as protective factors.

Conclusion

Reperfusion and revascularization capabilities of tertiary CM hospitals have improved significantly, but in-hospital mortality has not significantly decreased. Efforts are needed to improve medical awareness of AMI and expand the use of CM to reduce in-hospital mortality in China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. Summary of Chinese cardiovascular disease report 2017. Chin Circ J (Chin) 2018;33:1–8.

    Google Scholar 

  2. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2013;381:1987–2015.

    Article  Google Scholar 

  3. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 2015;385:402.

    Google Scholar 

  4. Liu HX, Wang SR, Zhao D, Lei Y. Comparative analysis on clinical characteristics and therapeutic status of inpatients with acute myocardial infarction in TCM and Western Medicine Hospitals in Beijing. Int J Emerg Crit Care Med (Chin) 2007;4:1934–1937.

    Google Scholar 

  5. Wang SR, Liu HX, Zhao D, Lei Y, Wang W, Shang JJ. Study on the therapeutic status of 1,242 hospitalized acute myocardial infarction patients in Beijing. Chin J Epidemiol (Chin) 2006;11:991–995.

    Google Scholar 

  6. Zheng L, Liu HX, Shang JJ. Meta-analysis on the effects of TCM intravenous preparations on the case fatality rate and recanalization rate of acute myocardial infarction. J Emerg Tradit Chin Med (Chin) 2007;16:859–860.

    Google Scholar 

  7. Ying F, Liu HX. Fatality rate analysis of TCM treatment on acute myocardial infarction from clinical research literatures of China. Circ Cardiovasc Qual Outcomes (Chin) 2006;13:357–360.

    Google Scholar 

  8. Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of the Chinese Journal of Cardiology. The guidelines for the diagnosis and treatment of acute STEMI. Chin J Cardiol (Chin) 2015;43:380–393.

    Google Scholar 

  9. Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of the Chinese Journal of Cardiology. The guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes. Chin J Cardiol (Chin) 2012;40:353–367.

    Google Scholar 

  10. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–171.

    Article  Google Scholar 

  11. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151–1210.

    Article  Google Scholar 

  12. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002;25:1129–1134.

    Article  Google Scholar 

  13. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009;373:1765–1772.

    Article  CAS  Google Scholar 

  14. Li Y, Zeng X, Liu J, Liu Y, Liu S, Yin P, et al. Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030. BMC Med 2017;15:132.

    Article  Google Scholar 

  15. Liu HX, Gao W, Zhao D, Shang JJ, Sun JY. Survey on the hospitalization treatment status of acute myocardial infarction patients in 13 hospitals of Western medicine and TCM in Beijing. Chin J Cardiol (Chin) 2010;38:306–310.

    Google Scholar 

  16. Wang N, Zhao D, Liu J, Liu J, Yu CM, Wang W, et al. Impact of heart failure on in-hospital outcomes of acute coronary syndrome patients in China—results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) project. Int J Cardiol 2012;160:15–19.

    Article  Google Scholar 

  17. Beta-Blocker Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. Eur Heart J 1988;9:8–16.

    Article  Google Scholar 

  18. Gottlieb SS, McCarter RJ, Vogel RA. Effect of β-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489–497.

    Article  CAS  Google Scholar 

  19. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139–e228.

    Article  Google Scholar 

  20. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458–2473.

    Article  Google Scholar 

  21. Shang JJ, Shi H, Zhou Q, Gao W, Liu HX. A study of prognosis, outcome, and changing tendency of hospitalized AMI patients in Beijing tertiary TCM hospitals from 1999 to 2008. Evid Based Complement Alternat Med 2012;2012:837194.

    PubMed  PubMed Central  Google Scholar 

  22. Liu LS, Wang W, Fang QY, Pan WX, Huang P, Ma FZ, et al. Effects of captopril combined with other drugs on important clinical events in patients with acute myocardial infarction—Sixth special report from the Chinese Cardiac Study-1 (CCS-1). J Hyperten (Chin) 1998;3:7–10.

    Google Scholar 

  23. Wang Y, Xiao L, Mu W, Yu HL, Zhang S, Tian GH, et al. A summary and evaluation of current evidence for myocardial infarction with Chinese medicine. Chin J Integr Med 2017;23:948–955.

    Article  Google Scholar 

  24. Jin YY, Gao H, Zhang XY, Ai H, Zhu XL, Wang J. Shenfu Injection inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock. Chin J Integr Med 2017;23:170–175.

    Article  Google Scholar 

  25. Duan WH, Lu F, Li LZ, Wang CL, Liu JG, Yang QN, et al. Clinical efficacy of traditional Chinese medicine on acute myocardial infarction: a prospective cohort study. Chin J Integr Med 2012;18:807–812.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are greatly appreciative of the staff members of all of the participating hospitals for their outstanding efforts: Dongfang Hospital, Beijing University of Chinese Medicine; Xiyuan Hospital, China Academy of Chinese Medical Sciences; Dongzhimen Hospital, Beijing University of Chinese Medicine; Guang’anmen Hospital, China Academy of Chinese Medical Sciences; Wangjing Hospital of China Academy of Chinese Medical Sciences; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; Shijiazhuang Traditional Chinese Medicine Hospital; Tangshan Hospital of Traditional Chinese Medicine; Jilin Province Hospital of Traditional Chinese Medicine; Henan Province Hospital of Traditional Chinese Medicine; the First Affiliated Hospital of Henan University of Traditional Chinese Medicine; Qingdao Hai Ci Hospital Group; Shanxi Traditional Chinese Medicine Hospital; Liaoning Traditional Chinese Medicine Hospital; Inner Mongolia Hospital of Traditional Chinese Medicine; Xinjiang Uygur Hospital of Traditional Chinese Medicine; Zhejiang Province Hospital of Traditional Chinese Medicine; Jiangsu Province Hospital of Chinese Medicine; the First Affiliated Hospital of Guangxi University of Chinese Medicine; the Affiliated Hospital of Fujian University of Traditional Chinese Medicine; Guangdong Province Hospital of Traditional Chinese Medicine; The First Hospital of Hunan University of Chinese Medicine; Heilongjiang Province Hospital of Traditional Chinese Medicine, Gansu Province Clal Hospital of Traditional Chinese Medicine; Yunnan Province Hospital of Traditional Chinese Medicine; Baoding No. 1 Hospital of Traditional Chinese Medicine; The Affiliated Hospital of Shandong University of Traditional Chinese Medicine; Wuxi Hospital of Traditional Chinese Medicine; Hangzhou Hospital of Traditional Chinese Medicine; The Affiliated Hospital of Changchun University of Traditional Chinese Medicine; Third Affiliated Hospital of Henan University of Traditional Chinese Medicine; Wuhu Hospital of Traditional Chinese Medicine; Jiangxi Province Hospital of Traditional Chinese Medicine; Shiyan Hospital of Traditional Chinese Medicine; Ningxia Chinese Medicine Research Center; Hospital of Traditional Chinese Medicine and Hui Nationality Medicine Affiliated to Ningxia Medical University.

Author information

Authors and Affiliations

  1. Department of Cardiovascular, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China

    Xiao-lei Lai, Hong-xu Liu, Xin Hu, Ju-ju Shang, Xiang Li, Qi Zhou & Wen-long Xing

  2. Department of Rehabilitation, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, 100102, China

    Jing-feng Tian

Authors
  1. Xiao-lei Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong-xu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing-feng Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ju-ju Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qi Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wen-long Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Lai XL wrote the manuscript. Liu HX was responsible for quality control of the study. Shang JJ was responsible for the design of the study protocol. Hu X and Tian JF were jointly responsible for patient recruitment. Zhou Q and Xing WL were responsible for outcome data collection. Li X was responsible for statistical data analysis. All authors critically reviewed the content and approved the final version of this manuscript.

Corresponding author

Correspondence to Hong-xu Liu.

Additional information

Conflicts of Interest

The authors declare no conflict of interest.

Supported by Beijing Municipal Administration of Hospitals Key Medical Professional Development Program (No. ZYLX201817)

Electronic Supplementary Material

11655_2020_3189_MOESM1_ESM.pdf

Acute Myocardial Infarction in Chinese Medicine Hospitals in China from 2006 to 2013: An Analysis of 2311 Patients from Hospital Data

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, Xl., Liu, Hx., Hu, X. et al. Acute Myocardial Infarction in Chinese Medicine Hospitals in China from 2006 to 2013: An Analysis of 2311 Patients from Hospital Data. Chin. J. Integr. Med. 27, 323–329 (2021). https://doi.org/10.1007/s11655-020-3189-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-020-3189-1

Keywords

Search

Navigation